siRNA沉默细胞外信号调节激酶1/2基因协同甲亢宁胶囊对大鼠甲状腺细胞—5细胞增殖的影响
2016-05-30林兰王秋虹易泳鑫
林兰 王秋虹 易泳鑫


摘要:目的 通过甲亢宁胶囊(以下简称“甲亢宁”)协同siRNA干扰大鼠甲状腺细胞-5(fisher rat thyroid cell line-5,FRTL-5)中细胞外信号调节激酶(ERK)1/2基因,观察并探讨甲亢宁对FRTL-5细胞RNA干扰ERK1/2基因表达及对FRTL-5细胞增殖的影响。方法 将生长状态良好的FRTL-5细胞分为空白组、阴性对照组、甲亢宁组、siRNA组、甲亢宁协同组。利用siRNA沉默及甲亢宁协同干扰FRTL-5细胞的ERK1/2基因,RT-PCR检测ERK1/2 mRNA表达,Western blot检测ERK1/2、p-ERK1/2蛋白表达,CCK8法检测细胞增殖。结果 RT-PCR检测结果显示,空白组和阴性对照组ERK1/2的mRNA表达无明显差异(P>0.05);与空白组比较,siRNA组和甲亢宁组FRTL-5细胞ERK1/2 mRNA表达明显下降(P<0.01);与空白组、阴性对照组比较,甲亢宁协同组ERK1/2 mRNA表达明显下降(P<0.01);Western blott检测结果显示,与空白组、阴性对照组比较,甲亢宁组、siRNA组、甲亢宁协同组p-ERK1/2、ERK1/2蛋白表达相对量明显下降(P<0.01)。转染24、48 h后,CCK8法检测结果显示,甲亢宁组、siRNA组、甲亢宁协同组细胞增殖受抑制,与空白组、阴性对照组比较差异有统计学意义(P<0.01)。结论 甲亢宁对ERK1/2磷酸化起阻断作用,ERK1/2基因被沉默后,对甲状腺细胞增殖有抑制作用,甲亢宁可协同ERK1/2-siRNA抑制FRTL-5细胞增殖。
关键词:甲状腺细胞;细胞外信号调节激酶1/2;甲亢宁胶囊;RNA干扰;增殖
DOI:10.3969/j.issn.1005-5304.2016.06.012
中图分类号:R285.5 文献标识码:A 文章编号:1005-5304(2016)06-0043-04
Abstract: Objective To observe and explore the effects of Jiakangning Capsules on the expression of ERK1/2 gene and proliferation of FRTL-5 by studying the effects of Jiakangning Capsules collaborated with siRNA on interfering ERK1/2 gene in FRTL-5. Methods FRTL-5 cells in good conditions were divided into control group, negative control group, Jiakangning Capsules collaborated with siRNA group, siRNA interference group, and Jiakangning Capsules group. RT-PCR was performed to detect the expression of ERK1/2 gene in mRNA levels in FRTL-5; Western blotting was performed to detect the expressions of ERK1/2 and p-ERK1/2; CCK8 method was used to detect cell proliferation. Results RT-PCR results showed that the ERK1/2 mRNA expression of the control group and negative control group were of no significant difference (P>0.05); compared with the control group, siRNA interference group and Jiakangning Capsules group could inhibit ERK1/2 gene mRNA expression in FRTL-5 (P<0.01). Compared with the control group and negative control group, the ERK1/2 mRNA expression of Jiakangning Capsules collaborated with siRNA group decreased obviously (P<0.01). Compared with the control group and negative control group, the expression of p-ERK1/2, ERK1/2 of Jiakangning Capsules group, Jiakangning Capsules collaborated with siRNA group, and siRNA interference group decreased obviously (P<0.01). At the time of 24 h and 48 h after transfection, according to the results of CCK8, compared with the control group and negative control group, the cell proliferation of Jiakangning Capsules group, Jiakangning Capsules collaborated with siRNA group, and siRNA interference group was inhibited (P<0.01). Conclusion Jiakangning Capsules have blocking effect on the phosphorylation of ERK1/2. After ERK1/2 gene was silenced, the thyroid cell proliferation was inhibited. Jiakangning Capsules can collaborate with ERK1/2-siRNA to inhibit FRTL-5 cell proliferation.
Key words: thyroid cell; ERK1/2; Jiakangning Capsules; RNA interference; proliferation
Graves病(Graves disease,GD)是当前常见的甲状腺疾病之一,临床典型表现为甲状腺肿大、Graves眼病和高代谢症候群等。GD是甲状腺功能亢进症的最常见病因[1]。但临床中应用抗甲状腺药物治疗普遍存在复发率高、治疗周期长的缺点[2-3]。目前,临床上对GD发病过程中“甲状腺细胞异常过度增殖”这一关键环节,尚缺乏针对性的治疗药物[4]。本研究以细胞外信号调节激酶(extracellular signal-regulated kinase,ERK)1/2基因为靶点,针对ERK1/2基因的siRNA特异性片段,采用Lipofectamine RNAiMAX Reagent转染试剂将其有效地转染入Fisher大鼠甲状腺细胞-5(fisher rat thyroid cell line-5,FRTL-5)细胞内,诱导ERK1/2基因沉默,从而研究RNAi效应对FRTL-5细胞ERK1/2基因表达的抑制作用及其对细胞增殖的抑制作用,探讨GD的治疗新策略。
1 实验材料
1.1 细胞
FRTL-5细胞(CRL1468)来源于ATCC细胞库。
1.2 药物及制备
甲亢宁胶囊(以下简称“甲亢宁”),中国中医科学院广安门医院,京药制字Z20063194,批号20151203。将1粒甲亢宁(0.45 g)溶于14.265 mL纯水中,配制成100 mg/mL甲亢宁母液,用0.22 μm滤器过滤至离心管,4 ℃保存。依据……
